MANE
Veradermics, Incorporated
116.80$
-0.4%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 24 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 93.5% | 99.6% | 99.9% | 99.6% | 99.9% | |
| 89.4% | 30.1% | 14.3% | 42.3% | 38.7% | |
| 89.4% | 80.5% | 93.0% | 98.0% | 99.3% | |
| 2.3% | 6.6% | 0.8% | 0.4% | – | |
| 7.9% | 610.8% | 179.3% | 1.7% | 1.5% | |
| 7.9% | 30.3% | 6.0% | 1.7% | 1.4% | |
| 3.8% | 10.6% | 1.4% | 0.3% | 0.7% | |
| 92.1% | -510.8% | -79.3% | 98.3% | 98.5% | |
| -82.9% | -518.1% | -80.9% | -37.8% | -21.1% | |
| 339.0% | 186.6% | 24.5% | 9.4% | 4.9% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.